We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 300 mg powder for injection vial with diluent vial, Eli Lilly Australia Pty Ltd, CON-1084
Product name
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 300 mg powder for injection vial with diluent vial
Sponsor name
Eli Lilly Australia Pty Ltd
Consent start
Consent no.
CON-1084
Duration
The consent is effective from 16 March 2023 until 30 September 2026.
Standard
Paragraphs 8(1)(f) and (g) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The products do not comply as the product labels do not have the batch and
expiry prefixes immediately preceding the batch and expiry variable data on the
carton and/or container labels.
Import, Supply, &/or Export
import, supply, and export
Therapeutic product type
Prescription medicines